Novo Nordisk’s once‐weekly injectable, Ozempic (semaglutide), originally developed for type 2 diabetes, has increasingly attracted attention in Egypt, not just for its blood-sugar-lowering benefits, but for its marked weight‐loss effect too. Clinical trials involving more than 10,000 adults led to its launch in the country in late 2021, and local specialists have hailed its ability to both control blood sugar and reduce body weight, thereby lowering cardiovascular risk, which account for more than a third of total deaths in the country, making Egypt the 15th highest country with coronary heart disease deaths in the world. For many Egyptians with uncontrolled diabetes, Ozempic has represented a breakthrough. “The results consistently showed greater reductions in both blood sugar and body weight compared with commonly used treatments for type 2 diabetes, as well as cardiovascular benefits, in people with 2 diabetes,” explained Abbas Oraby, Professor of Diabetes and Endocrinology, Zagazig University. Yet, as its benefits became more widely known, Ozempic’s potent effect on weight loss quickly led to off‐label use. Social media posts and testimonials all across the world have amplified its reputation as a “miracle” weight‐loss aid. Yasser Ferro, a 29-year-old softwareContinue reading "Ozempic’s Surge in Egypt Sparks Medical Praise, Public Demand, and Growing Fears"
Ozempic’s Surge in Egypt Sparks Medical Praise, Public Demand, and Growing Fears first appeared on Egyptian Streets.
Read More Details
Finally We wish PressBee provided you with enough information of ( Ozempic’s Surge in Egypt Sparks Medical Praise, Public Demand, and Growing Fears )
Also on site :
- Vacaville carjacking suspects arrested in Fairfield; suspect shot by police
- See photos of Jeff Bezos spanking bride-to-be Lauren Sánchez while lounging on $500M superyacht
- ‘80s Music Icon Poses Nude to Celebrate Her 67th Birthday